Intensive Care Med(2013) 39:2011–2019
DOI 10.1007/s00134-013-3085-7 ORIGINAL ARTICLE
D. H. de Gast-Bakker Safety and effects of two red blood cell
R. B. P. de Wilde
transfusion strategies in pediatric cardiac
M. G. Hazekamp
V. Sojak
surgery patients: a randomized controlled trial
J. J. Zwaginga
R. Wolterbeek
E. de Jonge
B. J. Gesink-van der Veer
)
R.B. P. deWilde ( ) volume of transfused RBC was 186
Received: 4April2013
Albinusdreef2, POBox9600, (±70)mlperpatientandintheliberal
Accepted: 19August2013
2300RCLeiden, The Netherlands
Published online:31August2013 transfusion group 258 (±87) ml per
e-mail: r.b.p.de_wilde@lumc.nl
(cid:2)Springer-Verlag Berlin Heidelbergand patient, (95 % CI 40.6–104.6),
Tel.:?31-71-5262619
ESICM2013 p\0.001. Length of hospital stay
Fax:?31-71-5266966
Thisarticle isdiscussed in was shorter in patients with a
theeditorial available at:doi: restrictive RBC transfusion strategy:
10.1007/s00134-013-3082-x. Abstract Objective: To investi- median 8 (IQR 7–11) vs. 9 (IQR
gate the safety and effects of a 7–14) days, p = 0.047. All other
Electronic supplementary material
The onlineversion of thisarticle restrictive red blood cell (RBC) outcome measures and incidence of
(doi:10.1007/s00134-013-3085-7) contains transfusion strategy in pediatric car- adverse effects were equal in both
supplementary material,which isavailable diac surgery patients. RBC transfusion groups. Cost of
toauthorized users. Design: Randomized controlled blood products for the liberal trans-
trial. Setting: Pediatric ICU in an fusion group was 438.35 (±203.39)
academic tertiary care center, Leiden vs. 316.27 (±189.96) euros (95 % CI
D.H.deGast-Bakker (cid:2)R.B.P.deWilde(cid:2) University Medical Center, Leiden, 46.61–197.51) per patient in the
E.de Jonge (cid:2)B. J.Gesink-vander Veer The Netherlands. Patients: One restrictive transfusion group,
Pediatric Intensive CareUnit, Leiden
hundred seven patients with non- p = 0.002. Conclusions: For
UniversityMedical Center,Leiden,
cyanotic congenital heart defects patients with a non-cyanotic congen-
The Netherlands
between 6 weeks and 6 years of age. ital heart defect undergoing elective
M.G.Hazekamp (cid:2) V.Sojak Onehundredthreepatientsunderwent cardiac surgery, a restrictive RBC
Department of Cardiothoracic Surgery, corrective surgery on cardiopulmo- transfusion policy (threshold of Hb
LeidenUniversity Medical Center,Leiden, nary bypass. Interventions: Prior to 8.0 g/dl) during the entire periopera-
The Netherlands surgery patients were randomly tive period is safe, leads to a shorter
assigned to one of two groups with hospital stay and is less expensive.
J.J.Zwaginga
specific RBC transfusion thresholds:
Center forClinical Transfusion Research,
SanquinResearch,Leiden,TheNetherlands Hb 10.8 g/dl (6.8 mmol/l) and Hb Keywords Pediatrics (cid:2)
8.0 g/dl (5.0 mmol/l). Measure- Cardiac surgery (cid:2) Critical care (cid:2)
J.J.Zwaginga ments: Length of stay in hospital Randomized clinical trial (cid:2)
Department of Immuno-hematology and (primary outcome), length of stay in Erythrocyte (cid:2) Transfusion
Blood Transfusion,LeidenUniversity PICU, duration of ventilation (sec-
Medical Center, Leiden,The Netherlands
ondary outcome), incidence of
adverse events and complications
R. Wolterbeek
related to randomization (intention to
Department of Medical Statistics and
Bioinformatics, LeidenUniversity Medical treat analysis). Results: In the
Center, Leiden,The Netherlands restrictive transfusion group, mean
2012
Introduction care center. The study was approved by the institutional
Ethics Committee (protocol P07.186).
Blood transfusions can be lifesaving in patients with
excessive bleeding or severe anemia. A retrospective
survey among pediatric intensive care units in the USA Study population
showed that 54.5 % of all children with a pre-transfusion
hemoglobinconcentration(Hb)below9 g/dl(5.6 mmol/l) Between April 2009 and January 2012, 162 eligible
receivedatleastoneredbloodcell(RBC)transfusion[1]. patients were scheduled for elective surgery for a non-
Although transfusion practice has become increasingly cyanotic congenital heart defect. Inclusion criteria were
safe over the years, numerous data published in the past elective surgery for a congenital heart defect; patients
decade have demonstrated various deleterious effects of between 6 weeks and 6 years of age and peripheral oxy-
blood transfusions [2–11]. Therefore, current transfusion gen saturation (SpO ) above 95 % on admission.
2
practice has evolved to increasingly restrictive use of All parents/legal guardians received written informa-
blood product transfusions in adults [12–14]. tionaboutthestudyprotocolpriortoscheduledadmission
Up until quite recently, it has been a widely held belief to the hospital. Additional verbal information was pre-
that withholding blood transfusions to anemic young chil- sented to the parents/legal guardians on the day of
dren, especially infants, is harmful. Children have an hospital admission. Prior to anesthesia and surgery,
increasedmetabolicrateandthusanincreasedtissueoxygen written informed consent was obtained from all parents/
demandcomparedtoadults,whileatthesametimetheyhave legal guardians. Upon request of parents/legal guardians,
alimitedabilitytoincreasetheircardiacoutputtocompen- patients could be withdrawn from study participation at
sate for a fall in Hb. Like in adults, pediatric studies have any time.
demonstrated not only anincrease in morbidity but also an
increased mortality associated with RBC transfusion [5–8,
15–17]. Most patients, also children, tolerate lower hemo- Study protocol
globinlevelsthanwerepreviouslyheldappropriateforthis
agegroup,withoutanydeleteriouseffects[9,14,18–26]. In a single-center open-labeled randomized controlled
Since the landmark paper by Lacroix [27], which trial, the safety and effects of two RBC-transfusion poli-
demonstrated that a restrictive RBC transfusion strategy cies were determined in pediatric patients with a non-
with an Hb threshold of 7 g/dl (4.4 mmol/l) in stable, cyanotic congenital heart defect that required elective
critically ill children decreases transfusion requirements cardiac surgery.
without increasing adverse outcome, clinicians have After written informed consent, sealed randomization
questioned the need for a higher Hb in the pediatric envelopes were opened. Patients were allocated to one of
population [15, 16, 28, 29]. However, a well-defined Hb twotransfusionstrategies.Intheliberaltransfusiongroup
threshold value to use for making the decision when to (group A) patients received RBC transfusion if their Hb
transfuseornotisunavailable[15,16,18–21,28,30,31]. concentration dropped below 10.8 g/dl (6.8 mmol/l). In
Perioperative management in congenital heart surgery the restrictive transfusion group (group B), patients
is aimed at maximizing systemic oxygen delivery. It is received an RBC transfusion if their Hb concentration
generally believed that oxygen delivery can be improved was 8.0 g/dl (5.0 mmol/l) or less. When a threshold was
by increasing Hb; therefore, treatment of anemia is the reached, each patient was to receive an RBC transfusion
main rationale for transfusing children after cardiac sur- of 10 ml/kg. RBC units were always leukocyte-depleted.
gery [9, 15–17, 20, 21, 32]. This concept, however, has The transfusion policy was to be adhered to from induc-
never been proven [9, 28, 32]. tion of anesthesia until hospital discharge. All other
The published experience with restrictive RBC trans- aspects of patient care were left to the discretion of the
fusion strategies in pediatric cardiac surgery is not attending physician. Hb values were measured 1 day
extensive. Inthis studywe soughttodeterminethesafety beforetheoperation,atinductionofanesthesia,following
and effects of a restrictive RBC transfusion strategy in both initiation and discontinuation of cardiopulmonary
childrenundergoingcorrectivesurgeryforanon-cyanotic bypass (CPB) and directly on admission to the PICU. At
congenital heart defect. the PICU, Hb values are checked routinely, every 6 h for
the first 24 h after admission, if necessary more fre-
quently on an individual basis and thereafter once daily.
Transfusion thresholds were communicated to the
Methods and materials
attending physician and entered in the Patient Data
Setting Management System (PDMS) (Metavision, iMDsoft,
Needham, MA, USA) at bedside. Nurses were asked to
This randomized clinical trial was conducted at Leiden monitor and report blood loss and also to report all RBC
UniversityMedicalCenter(LUMC),anacademictertiary transfusions by entering the RBC transfusion volume and
2013
RBC bag ID number into the PDMS. When an RBC our hospital. After induction of anesthesia, dexametha-
transfusion was either withheld or administered in con- sone (0.5 mg/kg) was administered to all patients.
tradiction to the randomization protocol, this was Intraoperative use of antifibrinolytic agents (tranexamic
considered a protocol violation. acid)andcellsalvageareroutineatthestudysite.Patients
received milrinone, norepinephrine or dobutamine at the
discretion of the attending anesthetist and surgical team.
Anesthesia and CPB Perioperative antibiotic prophylaxis consisted of 24 h of
cefazoline.
Anesthesia was performed with inhalation of sevoflurane
followed by intravenous administration of pancuronium,
sufentanil and propofol in all patients. All patients were Data collection
intubated with a cuffed endotracheal tube (KimventTM
MicrocuffTM, Kimberly-Clark Health Care, Roswell, GE, Data collection consisted of demographic data, cardiac
USA) and ventilated according to institutional protocol. diagnosis, RACHS-1 score [33], duration of CPB, aortic
All patients received a peripheral venous catheter, an cross-clamptime,PRISMII/IIIandPIM2scores[34,35],
arterial canula and a central venous PediaSat Oximetry blood loss and blood transfusion data. Data recorded
Catheter (Edwards Lifesciences, Irvine, CA, USA). The directly from PDMS included heart rate (HR), arterial
PediaSatcatheter was preferably sitedinthe right jugular blood pressure (ABP), central venous pressure (CVP),
vein for additional monitoring of central venous oxygen centralvenousoxygensaturation(ScvO 2),cerebralregio-
saturation (ScvO 2). Additional monitoring in the operat- nal O 2 saturation of the left and right hemisphere (rSO 2),
ing theatre and PICU included bilateral cerebral oxygen bodytemperatureandventilatorsettings.Additionally,we
saturation with a Somanetics Invos Cerebral Oximeter recordedprotocoladherence,incidenceof(serious)adverse
(Covidien,Mansfield,MA, USA)and depthof anesthesia events,complicationsanduseofconcomitantmedication.
with the Bispectral index (compact BISx Power LinkTM,
Philips, Eindhoven, The Netherlands). The last two
monitoringtoolsarestandardcareforallpediatriccardiac End points
operations performed at our hospital.
Cardiopulmonary bypass was performed using phos- The primary outcome measure was in-hospital length of
phorylcholine-coated closed circuit tubing and a hollow- stay (LOS), calculated in days.
fiber membrane oxygenator (Sorin Group Italia, Miran- SecondaryoutcomeswerePICULOS(days),duration
dola,Modena,Italy),usingstandardtechniquesaccording of mechanical ventilatory support (defined as the time
to age and weight. The CPB circuit was primed with between induction of anesthesia and extubation at the
crystalloid and colloid solutions. Mannitol, albumin, PICU, and expressed in hours) and incidence of all
RBCs and fresh frozen plasma (FFP) were added to the reported (serious) adverse events, complications and
bypass circuit as needed. The amount of RBCs was transfusioncosts.Respiratoryinfections(definedasfever,
individually calculated using the following variables: leucocytosis, signs on chest X-ray and a positive sputum
bodyweight, preoperative hematocrit and prime volume: culture) were noted as a complication. Re-thoracotomy,
hemato- or pneumothorax and resuscitation (CPR) were
CV¼weight(cid:3)80ml, registered as serious adverse events and were reported to
theinstitutionalethicscommittee.Costsofbloodproducts
Ek¼CV(cid:3)Ht,
were calculated in euros based on information from the
Tv¼CVþCPB volume, Sanquin Blood Bank, Leiden, The Netherlands.
En¼Tv(cid:3)0:25;
Statistical analysis
En(cid:4)Ek=0:55 ¼ ml RBC needed for prime:
In this calculation, CV = circulating blood volume, Assuming a significant difference in hospital LOS from
Ek = volume of erythrocytes, Tv = total volume, and 20.1 (±21.8) (group A) to 10.1 (±10.9) (group B), we
En = thecalculatedamountoferythrocytesresultingina estimatedthat48patients wouldbeneededpergroupfora
Ht of 0.25. power of 0.8 and an alpha of 0.05 (Department of Medical
Myocardial protection was achieved with cold crys- Statistics and Bioinformatics, Leiden University).
talloid cardioplegia. After separation from CPB, heparin Statistical analysis was conducted according to an
was reversed with protamine 3 mg/kg or more as neces- intention-to-treat approach.
sary in order to normalize the activated clotting time to Continuousvariablesaredescribedasmeanwith(SD)
the preoperative value. On completion of CPB, perform- ormedianswithinterquartilerange(IQR)ifthedatawere
ingmodifiedultra-filtration(MUF)iscommonpracticein notnormallydistributed.Basedondistribution,continuous
2014
variables were tested with the Mann-Whitney U test or transfused RBC volumes in the liberal group (A) and
Student’s t test, when appropriate. Categorical variables restrictive group (B) were 258 (±87) vs. 186 (±70) ml
are described as numbers (n) and percentages. The cate- per patient (95 % CI 40.6–104.6), p\0.001. Average
goricalvariableswereexaminedusingachi-squaretestor blood loss due to production from the chest tube and due
Fisher’sexacttest(iftheexpectednumberinanycellwas to blood withdrawal was comparable between groups
\5).AKaplan-Meiercurvewascalculatedandplottedto (Table 2).
assesshospitalLOS,PICULOSanddurationofventilatory Red blood cell units used for transfusion were up to
support.Theeffectofadifferenceingenderdistributionin 30 daysold.TheaveragestoragetimeoftransfusedRBCs
thetwogroupswasevaluatedinaCoxregressionanalysis. in this study was 9.8 (±7.0) days. Storage time was not
Differences between group A and B were considered sig- different between the two study groups (p = 0.990)
nificantwithtwo-sidedpvaluesB0.05.Dataanalysiswas (Table 2).
performedusingSPSS20(Chicago,IL,USA).
Primary outcome results
Length of stay in hospital was 9 (7–14) days for the lib-
Results eral transfusion group (A), whereas for the restrictive
transfusion group (B), it was 8 (7–11) days, log-rank test
Between April 2009 and January 2012, a total of 162 p = 0.047 (Fig. 2). Gender included in the Cox regres-
patients with non-cyanotic congenital heart defects were sion model with group as the main predictor changed the
eligibleforparticipationinthestudy.In55cases,patients probability ratio (hazard ratio) of hospital discharge
were not eligible for randomization (Fig. 1). slightly from 1.422 to 1.434 (p = 0.079) in favor of the
After obtaining informed consent, we enrolled 107 restrictive transfusion group. Gender itself was not a
patientsintothestudy.Afterrandomization,thestudywas significantpredictor(p = 0.911).Nore-admissionstothe
discontinued in seven patients because of a protocol PICU were recorded during the entire study period, and
violation (Fig. 1). Of these seven patients, four (aortic every patient was discharged home alive.
coarctation) were operated on without CPB and required
minimal or no RBC transfusions. For ethical consider-
ations(thechanceofrandomizationintheliberalgroupA Secondary outcome results
andtherebyforcedRBCtransfusions),patientswithaortic
coarctation were excluded by approved addendum to the Duration of mechanical ventilation and LOS in PICU
original study protocol. (days) did not differ. All (serious) adverse events and
The 107 patients had a median age of 8.4 (IQR complications were recorded during the PICU stay
3.2–29.5) months, with a median weight of 7.2 (IQR (Table 3). Of the postoperative complications during the
5.0–12.0) kg, and 53 % were male. There were no sig- PICU stay, respiratory infections were most frequently
nificant differences between the groups with regard to observed: in five patients in group A; in six patients in
age,weight,RACHS-1,PRISMandPIMscores.Duration groupB,p = 0.726.Afterextubationonepatientingroup
of the operation, duration of CPB and cross-clamp time A and three patients in group B needed re-intubation,
were similar for both groups. Characteristics of the p = 0.302.Theincidenceofseriousadverseeventssuchas
patientsaccordingtoallocationarelistedinTable 1.Data hemato- or pneumothorax, re-thoracotomy and resuscita-
inspectionshowedapossiblynon-negligibledifferencein tion(CPR)atthePICUwasequalinbothgroups(n = 3).
gender distribution. Postoperatively, milrinone and norepinephrine were
All patients had comparable Hb values the day before administered in an equal number of patients in both
andatthestartoftheoperation.DuringCPBandsurgery, groups. However, the average dose of norepinephrine in
an equal amount of RBC and FFP was transfused in both patients in group A of 0.09 (±0.08) lg/kg/min was
groups (Electronic Supplementary Material), resulting in slightly higher than in patients in group B with 0.07
equal Hb values directly after the CPB and MUF proce- (±0.09) lg/kg/min, p = 0.003. Dobutamine was infre-
dure (Table 2). After CPB, Hb concentrations began to quentlyusedasavasoactivedruginbothstudygroups(in
diverge because of the implementation of the study pro- four patients in group A and seven patients in group B).
tocol.ThemeanHbconcentration,priortodischargefrom The total cost of transfused blood products calculated
thePICU,was12.2(±1.2)g/dl(7.5 ± 0.8 mmol/l)inthe per patient (RBCs and FFP combined) was 438.35
liberal transfusion group after 4.5 days compared to 10.2 (±203.39) euros in the liberal transfusion group
(±1.2) g/dl (6.4 ± 0.8 mmol/l) in the restrictive group (A)comparedto316.27(±189.96)eurosintherestrictive
after 3.6 days (95 % CI 1.44–2.39), p\0.001. All RBC transfusion group (B) (95 % CI 46.61–197.51),
transfusions were administered in the PICU, thus none p = 0.002.Thisresultedinacostreductionof28 %.The
during the remainder of the hospital stay. The mean cost of blood products is presented in detail in Table 3.
2015
Fig.1 CONSORTflowchart.ArandomizedcontrolledtrialevaluatingtwoRBCtransfusionstrategies(groupA:Hbthreshold10.8g/dl
and groupB: Hbthreshold 8.0g/dl)innon-cyanotic pediatricpatients withcorrective operationsforcongenital heart defects
Discussion
This randomized controlled trial demonstrated that a
restrictive transfusion strategy was safe in pediatric car-
Thisisthefirstrandomizedcontrolledtrialinvestigatinga diacsurgerypatientswithanon-cyanoticcongenitalheart
restrictive transfusion policy during the entire periopera- defect. We found no difference in morbidity between the
tive period (from induction of anesthesia right up to groups with the exception of a significant difference in
hospital discharge) in children undergoing surgery for length of hospital stay in favor of the patients in the
congenital heart disease. restrictive RBC transfusion group. These data are
2016
Table1 Patient characteristics in 107 non-cyanotic pediatric Table2 Hb concentrations, volume of transfused red blood cells, fresh
cardiac surgerypatients frozenplasmaandbloodlossin107pediatriccardiacsurgerypatients
GroupA, GroupB, GroupA, GroupB, pvalue
n=54 n=53 n=54 n=53
Hb10.8g/dl Hb8.0g/dl Hb10.8g/dl Hb8.0g/dl
Age(months) 7.3[3.0–29.7] 9.5[3.6–30.4] Hbpriortosurgery(g/dl) 11.9(1.5) 12.2(1.2) 0.245
Weight (kg) 7.1[4.9–12.9] 7.9[5.0–12.0] RBCduringsurgery(ml/patient) 158(54) 148(53) 0.336
Gender (female/male) 31/23 19/34 FFPduringsurgery(ml/patient) 148(50) 146(78) 0.884
RACHS-1 score: HbafterCPBandMUF(g/dl) 10.4(1.1) 10.1(1.3) 0.168
Score=1 3 1 Hbvalueonadmittance 10.3(1.2) 9.6(1.1) 0.004
Score=2 37 34 toPICU(g/dl)
Score=3 14 18 Bloodlosschesttube 130(101) 139(95) 0.648
Surgerytime(min) 191(55) 190(51) (ml/patient)
Bypass-time (min) 94.8(41) 86.0(35) Bloodwithdrawal(ml/patient) 24(14) 21(12) 0.330
Aortic clamp-time(min) 59.6(32) 56.0(32) RBCinPICU(ml/patient) 120(72) 90(50) 0.087
FFPinPICU(ml/patient) 155 –
Lowest central body 30.6(3.5) 31.2(2.4)
TotalRBC(ml/patient) 259(90) 186(70) \0.001
temperature ((cid:3)C)
ScvO (PediaSat) (%)ab 70.7(11.8) 69.1(12.1) TotalFFP(ml/patient) 152(55) 144(77) 0.629
2 Numberoftransfused
ScvO venous blood 69.6(12.4) 67.5(13.7)
sam2 ple (%)a RBCunits:
RBC280ml 75 54
rSO
Lef2 t (%)a 67.5(9.2) 70.4(10.0) RBC65ml 18 6
Numberoftransfused 32 25
Right(%)a 68.3(9.4) 70.0(11.1)
FFPunits
PRISMII 6.4(4.4) 6.4(3.67)
AgeofRBC(days) 9.8(6.8) 9.8(7.2) 0.990
PRISMIII 3.23(2.90) 3.87(2.76)
PIM 2 -3.789 (0.404) -3.742 (0.556) Transfusion data in 107 non-cyanotic, pediatric cardiac surgery patients.
Comparison between two RBC transfusion strategies. Group A: liberal
Comparison of two RBC transfusion strategies: group A: liberal
transfusionstrategy;groupB:restrictivetransfusionstrategy
transfusion strategy; groupB: restrictivetransfusion strategy
Allvaluesarepresentedasmeanwithstandarddeviation(SD)
Age in months and weight in kg are presented as median and
RBC red blood cells, FFP fresh frozen plasma, CPB cardiopulmonary
interquartilerangebetweenbrackets[IQR].Allothervariablesare
bypass,MUFmodifiedultra-filtration,PICUpediatricintensivecareunit
presented as mean with standard deviation between parentheses
(SD)
RACHS-1 Risk Adjustment for Congenital Heart Surgery score,
PRISMIIandPRISMIIIPediatricRiskofMortalityscores,PIM2 strategy after cavo-pulmonary connection. The authors
Pediatric Index of Mortality score, ScvO 2 central venous oxygen concluded that a restrictive RBC transfusion strategy did
saturation, rSO cerebral oxygen saturation of the left and right
2 decreasethenumberoftransfusions,donorexposuresand
cerebral hemisphere
a Measurement prior tosurgical procedure potential risks in these children.
b ScvO (PediaSat) measurement before calibration The premise that an RBC transfusion will result in
2
improved oxygen delivery and thus decreased tissue
hypoxianolongerholdstrue.Recentdatahavesuggested
consistent with those reported in recently published that RBC transfusions might, through various mecha-
comparable studies on the risks and benefits of red cell nisms, contribute to a reduction in local oxygen delivery
transfusions in children, including pediatric cardiac sur- in the tissues, which may play a role in the negative
gical patients [15,16,27].The results fromthe TRIPICU outcomes associated with transfusions in critically ill
studypublishedbyLacroixetal.[27]demonstratedthata patients despite an increase in the global hemoglobin
restrictive RBC transfusion strategy with a hemoglobin concentration and a theoretical increase in global oxygen
thresholdofHb\7 g/dl(4.4 mmol/l)instable, critically delivery [29].
ill children decreases transfusion requirements without Tolerance of anemia differs over various populations.
increasing adverse outcomes. In a subgroup analysis of A healthy adult with normal compensatory mechanisms
pediatric cardiac surgery patients in the TRIPICU study, may be capable of dealing with lower Hb levels than an
Willems et al. [16] demonstrated that a restrictive RBC infant that has just undergone complex cardiac surgery.
transfusion strategy, as compared with a liberal strategy The critical Hb level, at which level the body can no
(with an Hb threshold of 9.5 g/dl; 5.9 mmol/l), was not longer compensate for a further fall in Hb, may vary
associated with any significant difference in multiorgan considerably, depending on many factors including age
dysfunctionsyndromeorlengthofPICUstay.Inthissub- and disease. In order to apply an appropriate blood
study, however, the storage time of transfused RBCs was transfusion management, it is necessary to know the
not similar in the two groups. Recently, Cholette et al. thresholdvalueofHbatwhichweneedtotransfuseblood
[15] demonstrated that children with single-ventricle to avoid tissue hypoxia. Unfortunately, we do not know
physiology did not benefit from a liberal transfusion the transfusion threshold for each individual patient.
2017
Results found in adults should not be generalized to
critically ill children as they have different diseases and
different adaptive responses compared with adults [30].
Onaverage,theHbvalueatwhichabloodtransfusion
is prescribed in critically ill children is 8.0 g/dl
(5.0 mmol/l), which seems to be consistent with the
current practice in many adult intensive care units [19].
WechoseanHbthresholdof8.0 g/dl(5.0 mmol/l)inour
study for the restrictive transfusion strategy group as we
felt this was a safe level in this patient group considering
the close monitoring for signs of inadequate tissue oxy-
genation. The choice of an Hb threshold of 10.8 g/dl
(6.8 mmol/l) in the liberal transfusion group in our study
wasbasedontheHblevelatwhichweroutinelyprescribe
blood transfusions to children after corrective surgery for
non-cyanotic cardiac lesions in our PICU.
Possible deleterious effects of ‘‘old’’ blood—although
almost exclusively found in studies involving non-leu-
kocyte-depleted blood products of more than 14 days
storage time—did not play a role in our study as equal
storage conditions were applied for the RBCs transfused
Fig.2 Kaplan-Meiercurvespresentingdifferenceinhospitalstay inbothgroups.Onaverage,thestoragetimewasequalin
(in days). Comparison of length of hospital stay in 107 non- both groups 9.8 (±6.8) vs. 9.8 (±7.2) days (Table 2).
cyanotic pediatric cardiac surgery patients with two RBC transfu- Despite the fact that this is the first randomized con-
sion strategies. For the liberal transfusion group (A), length of
trolled trial of a restrictive vs. liberal blood transfusion
hospitalstayis9(7–14)days,whereasfortherestrictivetransfusion
group (B),itis 8(7–11) days,log-rank testp=0.047 strategy in cardiac surgery patients encompassing the
whole perioperative period lasting up to the day of dis-
chargefromthehospital,thisstudyseemsinlinewiththe
In adult volunteers there is no evidence of impaired present findings on this issue.
tissue oxygenation until Hb levels fall to 4–5 g/dl A few limitations, however, have to be delineated.
(2.4–3.1 mmol/l) [31], while the optimal Hb in critically One limitation of our study is that it was conducted as a
illadultsisstillunknown.However,anHblevel between single-center study in a relatively homogeneous, lower
7.0and9.0 g/dlhasbeengenerallyaccepted,basedonthe risk cardiac surgical group of patients. This may limit
paper by Hebert et al. in 1999 [36]. generalization of the findings. In particular, cyanotic,
Table3 Outcome data and complications in a randomized controlled trial of two RBC transfusion strategies in 107 non-cyanotic
pediatriccardiac surgerypatients
Group A,n=54 GroupB, n=53 p value
Hb 10.8g/dl Hb8.0g/dl
Hbvalue atdischarge PICU (g/dl) 12.2 (1.2) 10.2(1.2) \0.001
Mechanical ventilation time(h) 16[9–27] 20[9–52] 0.930
LOS PICU (days) 2 [1–5] 2 [1–4] 0.358
LOS Hospital (days) 9 [7–14] 8 [7–11] 0.047
ComplicationsPICU (n) 11 15 0.339
Rethoracotomy/resuscitation (n) 1 2
JET(n) 1 –
Pneumothorax/hematothorax (n) 2 1
Respiratory tract infection (n) 5 6 0.726
Pleural effusion(n) 1 2
Bronchospasm(n) – 1
Re-intubation (n) 1 3 0.302
Costs RBC/FFPperpatient (€) 328.96/109.39 229.20/87.08
Total costs perpatient (€) 438.35 (203.39) 316.27(189.96) 0.002
Primary and secondary outcome data and reported (serious) adverse events in 107 non-cyanotic pediatric cardiac surgery patients. Hb
valuesarepresentedasmeanand(SD)betweenparentheses.MechanicalventilationtimeandLOSarepresentedasmedianwith[IQR]
betweenbrackets
LOS lengthof stay,JETjunctional ectopictachycardia
2018
single-ventriclepatients,inwhomthehemoglobinlevelis Conclusions
a more critical factor in oxygen delivery, were excluded.
Furthermore, our liberal transfusion trigger is based on Forpatientswithanon-cyanoticcongenitalheartdefect,a
local guidelines. restrictive RBC transfusion policy with a transfusion
Another limitation of the study is that we did not threshold of Hb 8.0 g/dl (5.0 mmol/l) during the entire
include a third arm based on individual patient status. In perioperative period is safe. Furthermore, restriction in
such an individualized study arm, instead of acting on a blood transfusion leads to a shorter duration of hospital
preset transfusion threshold, a blood transfusion would stay and is less expensive compared to a liberal transfu-
additionally be triggered by signs of inadequate tissue sion strategy.
oxygenation, such as increases in lactate concentrations
and decreased ScvO , thereby providing information on Conflicts of interest The authors declare nopotential conflicts of
2
the critical hemoglobin level. interest.
Basedontheresultsofthisstudy,therestrictiveblood
transfusion policy, with a transfusion threshold of Hb
8.0 g/dl (5.0 mmol/l), has now been implemented in our
pediatric intensive care unit.
References
1. GoodmanAM,PollackMM,PatelKM, 7. Kipps AK,Wypij D,Thiagarajan RR, 12. Hajjar LA,Vincent JL,Galas FR,
Luban NL(2003) Pediatricred blood BachaEA,Newburger JW(2011) Nakamura RE, Silva CM, SantosMH,
celltransfusions increase resource use. Bloodtransfusion is associated with FukushimaJ, KalilFR,Sierra DB,
J Pediatr142:123–127 prolongeddurationof mechanical Lopes NH, MauadT, RoquimAC,
2. HendricksonJE, HillyerCD (2009) ventilation ininfantsundergoing Sundin MR, LeaoWC, AlmeidaJP,
Noninfectiousserious hazards of reparativecardiac surgery. PediatrCrit Pomerantzeff PM,Dallan LO, Jatene
transfusion.AnesthAnalg108:759–769 CareMed 12:52–56 FB,Stolf NA, AulerJOJr (2010)
3. ChapmanCE, Stainsby D,Jones H, 8. Salvin JW,Scheurer MA, LaussenPC, Transfusion requirements after cardiac
LoveE,MasseyE,WinN,NavarreteC, WypijD,Polito A,BachaEA,Pigula surgery: theTRACS randomized
Lucas G,Soni N,MorganC, ChooL, FA,McGowan FX,CostelloJM, controlled trial.JAMA 304:1559–1567
CohenH,Williamson LM (2009)Ten Thiagarajan RR(2011) Blood 13. Vincent JL, HajjarLA (2013)What’s
years of haemovigilance reportsof transfusion afterpediatriccardiac new intransfusion policies? Intensive
transfusion-related acute lunginjury in surgeryisassociated withprolonged Care Med39:1002–1004
theUnitedKingdom and theimpact of hospitalstay.Ann ThoracSurg 14. RiversE,NguyenB,HavstadS,Ressler
preferential useof maledonor plasma. 91:204–210 J,Muzzin A,Knoblich B,Peterson E,
Transfusion 49:440–452 9. KuduvalliM, OoAY, NewallN, Tomlanovich M(2001) Early goal-
4. Baumgartner JM,Silliman CC,Moore GraysonAD,JacksonM,DesmondMJ, directed therapy inthetreatment of
EE, BanerjeeA,McCarter MD(2009) FabriBM,Rashid A(2005) Effectof severesepsisandsepticshock.NEnglJ
Storedredblood celltransfusion peri-operativeredbloodcelltransfusion Med 345:1368–1377
induces regulatory Tcells. JAm Coll on30-day and 1-year mortality 15. Cholette JM,Rubenstein JS,Alfieris
Surg208:110–119 followingcoronary artery bypass GM, PowersKS, EatonM,Lerner NB
5. SurgenorSD, Kramer RS,Olmstead surgery.Eur J Cardiothorac Surg (2011) Childrenwith single-ventricle
EM,RossCS,SellkeFW,LikoskyDS, 27:592–598 physiologydonotbenefit fromhigher
MarrinCA, HelmREJr,Leavitt BJ, 10. MohnleP,Snyder-Ramos SA,MiaoY, hemoglobin levelspostcavopulmonary
MortonJR, Charlesworth DC,Clough Kulier A,Bottiger BW,LevinJ, connection: resultsof aprospective,
RA,Hernandez F,Frumiento C,Benak ManganoDT (2011)Postoperative red randomized, controlled trialof a
A,DioData C,O’Connor GT(2009) bloodcelltransfusion and morbid restrictive versusliberal red-cell
The associationof perioperative red outcomeinuncomplicated cardiac transfusion strategy. PediatrCrit Care
bloodcell transfusions anddecreased surgerypatients.Intensive Care Med Med 12:39–45
long-term survivalaftercardiac 37:97–109 16. Willems A,HarringtonK,Lacroix J,
surgery. AnesthAnalg 108:1741–1746 11. OliverE,CarrioML,Rodriguez-Castro Biarent D,Joffe AR,Wensley D,
6. Kneyber MC, HersiMI,Twisk JW, D,Javierre C,Farrero E, TorradoH, DucruetT,HebertPC,Tucci M(2010)
Markhorst DG,Plotz FB(2007) Red Castells E,VenturaJL (2009) Comparison of two red-celltransfusion
bloodcell transfusion incritically ill Relationshipsamong haemoglobin strategies afterpediatriccardiac
childrenisindependently associated level, packedredcell transfusion and surgery: asubgroup analysis. Crit Care
withincreasedmortality.IntensiveCare clinical outcomesin patientsafter Med 38:649–656
Med 33:1414–1422 cardiac surgery. Intensive CareMed
35:1548–1555
2019
17. SzekelyA,CserepZ,SapiE,BreuerT, 24. Tweddell JS,Hoffman GM, Mussatto 30. DesmetL,LacroixJ(2004)Transfusion
NagyCA, VarghaP, Hartyanszky I, KA,Fedderly RT, BergerS, Jaquiss inpediatrics.CritCareClin20:299–311
Szatmari A,TreszlA (2009)Risksand RD,GhanayemNS, Frisbee SJ,Litwin 31. WeiskopfRB(1998)Doweknowwhen
predictors ofblood transfusion in SB(2002)Improved survival of to transfuseredcellsto treat acute
pediatricpatientsundergoingopenheart patientsundergoing palliation of anemia? Transfusion 38:517–521
operations. AnnThorac Surg hypoplasticleftheartsyndrome:lessons 32. Palmieri TL,Lee T,O’Mara MS,
87:187–197 learnedfrom 115consecutive patients. Greenhalgh DG(2007)Effectsof a
18. RoseffSD, LubanNL, MannoCS Circulation106:I82–I89 restrictive bloodtransfusion policy on
(2002)Guidelines forassessing 25. PearseR,DawsonD,FawcettJ,Rhodes outcomes inchildrenwith burninjury.
appropriatenessofpediatrictransfusion. A,GroundsRM,Bennett ED (2005) J BurnCareRes 28:65–70
Transfusion 42:1398–1413 Changes incentral venoussaturation 33. JenkinsKJ, Gauvreau K,Newburger
19. Armano R,Gauvin F, DucruetT, aftermajorsurgery, andassociation JW,Spray TL, MollerJH, IezzoniLI
Lacroix J(2005) Determinantsof red withoutcome.Crit Care9:R694–R699 (2002) Consensus-basedmethod for
bloodcell transfusions inapediatric 26. HoffmanGM, MussattoKA, Brosig risk adjustment forsurgeryfor
critical care unit:aprospective, CL,Ghanayem NS,Musa N,Fedderly congenital heart disease. J Thorac
descriptiveepidemiological study.Crit RT,Jaquiss RD, Tweddell JS(2005) Cardiovasc Surg123:110–118
CareMed 33:2637–2644 Systemic venous oxygensaturation 34. PollackMM,PatelKM, RuttimannUE
20. Mhanna MJ,SuperDM (2005)What aftertheNorwood procedure and (1996)PRISMIII:anupdatedpediatric
hemoglobinvalue should oneuse in childhoodneurodevelopmental risk of mortalityscore. Crit CareMed
transfusing a critically illchild?Crit outcome.JThorac Cardiovasc Surg 24:743–752
CareMed 33:2710–2711 130:1094–1100 35. Slater A,Shann F,Pearson G(2003)
21. Nahum E,BenAri J,SchonfeldT 27. LacroixJ, HebertPC,HutchisonJS, PIM2: arevised version ofthe
(2004)Bloodtransfusionpolicyamong HumeHA,TucciM,DucruetT,Gauvin paediatric indexofmortality. Intensive
Europeanpediatric intensive care F,ColletJP,ToledanoBJ,RobillardP, Care Med29:278–285
physicians. J Intensive CareMed JoffeA,BiarentD,MeertK,PetersMJ 36. Hebert PC,Wells G,Blajchman MA,
19:38–43 (2007)Transfusion strategies for Marshall J, MartinC,Pagliarello G,
22. Tweddell JS, HoffmanGM, Fedderly patientsinpediatricintensivecareunits. Tweeddale M,Schweitzer I,YetisirE
RT, GhanayemNS, Kampine JM, NEnglJ Med 356:1609–1619 (1999) Amulticenter, randomized,
BergerS, MussattoKA, Litwin SB 28. RouetteJ, TrottierH,DucruetT, controlled clinical trial oftransfusion
(2000)Patientsatriskforlowsystemic BeaunoyerM,Lacroix J,Tucci M requirements incritical care.
oxygen deliveryaftertheNorwood (2010)Redbloodcell transfusion Transfusion requirements in critical
procedure.Ann ThoracSurg thresholdinpostsurgical pediatric care investigators, Canadian critical
69:1893–1899 intensive carepatients: arandomized care trials group.NEngl J Med
23. Tweddell JS, HoffmanGM(2002) clinical trial.AnnSurg251:421–427 340:409–417
Postoperative management inpatients 29. MarikPE, CorwinHL (2008)Efficacy
withcomplex congenital heartdisease. ofredblood celltransfusion inthe
Semin ThoracCardiovasc SurgPediatr criticallyill:asystematicreviewofthe
Card SurgAnnu5:187–205 literature.CritCareMed36:2667–2674
